[Serious adverse effects of blood collection].
The notification of serious adverse events occurring resulting from the collection of blood or blood components is a statutory requirement. The value of this set of surveillance procedures is the use of data collected. This article focuses on the organization of the French notification system, and the management of the main side effects known and reported.
Établissement Français du Sang Bretagne, Rue Pierre-Jean-Gineste, 35000 Rennes, France. bruno.danic@efs.sante.fr
B
B
Danic
C
C
Lefort
D000925:Anticoagulants / Q000009:adverse effects; D001158:Arteries / Q000293:injuries; D001781:Blood Component Removal / Q000009:adverse effects*; D001782:Blood Donors; D019343:Citric Acid / Q000009:adverse effects; D006406:Hematoma / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D015994:Incidence; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality; D010146:Pain / Q000453:epidemiology / Q000209:etiology; D059348:Peripheral Nerve Injuries; D010689:Phlebitis / Q000453:epidemiology / Q000209:etiology; D018962:Phlebotomy / Q000009:adverse effects*; D019462:Syncope, Vasovagal / Q000209:etiology; D013746:Tetany / Q000139:chemically induced; D020246:Venous Thrombosis / Q000453:epidemiology / Q000209:etiology; D014947:Wounds and Injuries / Q000453:epidemiology
D000925:Anticoagulants; D019343:Citric Acid